Tag: Insurance: Medicare
Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes
Quarterly out-of-pocket costs increased by approximately $23 on average after age 65 years
New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss Drugs
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss
Million Hearts Model Cuts Five-Year Heart Attack, Stroke Risk in At-Risk Patients
Improved outcomes seen with no significant changes in Medicare spending
Major Drug Companies Agree to Price Negotiations With U.S. Government
Ten drugs have been chosen for price negotiations by the Centers for Medicare & Medicaid Services
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
CMS-qualified AUC for coronary artery disease heterogeneous, sometimes conflict with respect to appropriateness
Medicare Will Cover New Class of Alzheimer Drugs if Fully Approved by FDA, With...
Drug makers will also have to gather and keep data in a registry showing how the drugs are working in the real world
Medication for Opioid Use Disorder Dispensed More After Medicare Policy Change
Methadone dispensing up after 2020 without displacing use of buprenorphine
Medicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Other Countries Rate Half of Top-Selling Drugs in Medicare as Low Added Benefit
These low added therapeutic-rating drugs accounted for $19.3 billion or one-third of Medicare annual net spending in 2020
